Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia ; volume:12 ; number:1 ; day:8 ; month:12 ; year:2023 ; pages:115-129 ; date:3.2024
Oncology and Therapy ; 12, Heft 1 (8.12.2023), 115-129, 3.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Habr, Dany
Singh, Manmohan
Uehara, Roberto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40487-023-00254-3
- URN
-
urn:nbn:de:101:1-2404291417320.511891418559
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Habr, Dany
- Singh, Manmohan
- Uehara, Roberto
- SpringerLink (Online service)
Other Objects (12)
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Quality assurance of investigator initiated clinical trials in oncology
Discontinuation and nonpublication of clinical trials in orthopaedic oncology
Challenges in launching multinational oncology clinical trials in India
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Quality assurance of investigator initiated clinical trials in oncology
Discontinuation and nonpublication of clinical trials in orthopaedic oncology
Challenges in launching multinational oncology clinical trials in India
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Quality assurance of investigator initiated clinical trials in oncology
Discontinuation and nonpublication of clinical trials in orthopaedic oncology